123 related articles for article (PubMed ID: 17133269)
1. Mutations in BHD and TP53 genes, but not in HNF1beta gene, in a large series of sporadic chromophobe renal cell carcinoma.
Gad S; Lefèvre SH; Khoo SK; Giraud S; Vieillefond A; Vasiliu V; Ferlicot S; Molinié V; Denoux Y; Thiounn N; Chrétien Y; Méjean A; Zerbib M; Benoît G; Hervé JM; Allègre G; Bressac-de Paillerets B; Teh BT; Richard S
Br J Cancer; 2007 Jan; 96(2):336-40. PubMed ID: 17133269
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of BHD in sporadic renal tumors.
Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of Birt-Hogg-Dubé associated renal carcinoma.
Murakami T; Sano F; Huang Y; Komiya A; Baba M; Osada Y; Nagashima Y; Kondo K; Nakaigawa N; Miura T; Kubota Y; Yao M; Kishida T
J Pathol; 2007 Apr; 211(5):524-531. PubMed ID: 17323425
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia.
Chen J; Futami K; Petillo D; Peng J; Wang P; Knol J; Li Y; Khoo SK; Huang D; Qian CN; Zhao P; Dykema K; Zhang R; Cao B; Yang XJ; Furge K; Williams BO; Teh BT
PLoS One; 2008; 3(10):e3581. PubMed ID: 18974783
[TBL] [Abstract][Full Text] [Related]
5. Birt-Hogg-Dubé syndrome, a genodermatosis that increases risk for renal carcinoma.
Schmidt LS
Curr Mol Med; 2004 Dec; 4(8):877-85. PubMed ID: 15579035
[TBL] [Abstract][Full Text] [Related]
6. Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas.
Rebouissou S; Vasiliu V; Thomas C; Bellanné-Chantelot C; Bui H; Chrétien Y; Timsit J; Rosty C; Laurent-Puig P; Chauveau D; Zucman-Rossi J
Hum Mol Genet; 2005 Mar; 14(5):603-14. PubMed ID: 15649945
[TBL] [Abstract][Full Text] [Related]
7. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour.
Contractor H; Zariwala M; Bugert P; Zeisler J; Kovacs G
J Pathol; 1997 Feb; 181(2):136-9. PubMed ID: 9120715
[TBL] [Abstract][Full Text] [Related]
8. Underexpression of hepatocyte nuclear factor-1β in chromophobe renal cell carcinoma.
Wang CC; Mao TL; Yang WC; Jeng YM
Histopathology; 2013 Mar; 62(4):589-94. PubMed ID: 23237209
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.
da Silva NF; Gentle D; Hesson LB; Morton DG; Latif F; Maher ER
J Med Genet; 2003 Nov; 40(11):820-4. PubMed ID: 14627671
[TBL] [Abstract][Full Text] [Related]
10. Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma.
Nagy A; Zoubakov D; Stupar Z; Kovacs G
Int J Cancer; 2004 Apr; 109(3):472-5. PubMed ID: 14961590
[TBL] [Abstract][Full Text] [Related]
11. Cystic kidney disease, chromophobe renal cell carcinoma and TCF2 (HNF1 beta) mutations.
Lebrun G; Vasiliu V; Bellanné-Chantelot C; Bensman A; Ulinski T; Chrétien Y; Grünfeld JP
Nat Clin Pract Nephrol; 2005 Dec; 1(2):115-9. PubMed ID: 16932376
[TBL] [Abstract][Full Text] [Related]
12. FLCN gene-mutated renal cell neoplasms: mother and daughter cases with a novel germline mutation.
Nagashima Y; Furuya M; Gotohda H; Takagi S; Hes O; Michal M; Grossmann P; Tanaka R; Nakatani Y; Kuroda N
Int J Urol; 2012 May; 19(5):468-70. PubMed ID: 22211584
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the Birt-Hogg-Dube tumour suppressor gene (FLCN) in familial and sporadic colorectal cancer.
Nahorski MS; Lim DH; Martin L; Gille JJ; McKay K; Rehal PK; Ploeger HM; van Steensel M; Tomlinson IP; Latif F; Menko FH; Maher ER
J Med Genet; 2010 Jun; 47(6):385-90. PubMed ID: 20522427
[TBL] [Abstract][Full Text] [Related]
14. Multifocal and microscopic chromophobe renal cell carcinomatous lesions associated with 'capsulomas' without FCLN gene abnormality.
Sugimoto K; Takasawa A; Ichimiya S; Murata M; Kimura H; Aoyama T; Gille JJ; Kuroda N; Shimizu H; Hasegawa T; Sawada N; Furuya M; Nagashima Y
Pathol Int; 2013 Oct; 63(10):510-5. PubMed ID: 24134681
[TBL] [Abstract][Full Text] [Related]
15. High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors.
Vocke CD; Yang Y; Pavlovich CP; Schmidt LS; Nickerson ML; Torres-Cabala CA; Merino MJ; Walther MM; Zbar B; Linehan WM
J Natl Cancer Inst; 2005 Jun; 97(12):931-5. PubMed ID: 15956655
[TBL] [Abstract][Full Text] [Related]
16. Birt-Hogg-Dubé (BHD) gene mutations in human gastric cancer with high frequency microsatellite instability.
Jiang W; Fujii H; Matsumoto T; Ohtsuji N; Tsurumaru M; Hino O
Cancer Lett; 2007 Apr; 248(1):103-11. PubMed ID: 16870330
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the Birt Hogg Dube gene in patients with multiple lung cysts and recurrent pneumothorax.
Gunji Y; Akiyoshi T; Sato T; Kurihara M; Tominaga S; Takahashi K; Seyama K
J Med Genet; 2007 Sep; 44(9):588-93. PubMed ID: 17496196
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
19. Birt-Hogg-Dubé syndrome with clear-cell and oncocytic renal tumour and trichoblastoma associated with a novel FLCN mutation.
Imada K; Dainichi T; Yokomizo A; Tsunoda T; Song YH; Nagasaki A; Sawamura D; Nishie W; Shimizu H; Fukagawa S; Urabe K; Furue M; Hashimoto T; Naito S
Br J Dermatol; 2009 Jun; 160(6):1350-3. PubMed ID: 19416240
[No Abstract] [Full Text] [Related]
20. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]